Navigation Links
NACCHO to Support Influenza Vaccination Efforts With Donation of Up to One Million Doses of FluMist(R)
Date:12/10/2008

WASHINGTON, Dec. 10 /PRNewswire/ -- The National Association of County and City Health Officials (NACCHO) today announced a donation of up to one million doses of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) by MedImmune in a partnership aimed at increasing influenza awareness and vaccinations in underserved communities and populations.

NACCHO will make these donated doses of vaccine available to selected state and local health departments around the country starting this month. This joint NACCHO-MedImmune effort supports the goal of the Centers for Disease Control and Prevention (CDC) to broaden the influenza vaccination season into December and beyond. The CDC has launched National Influenza Vaccination Week (December 8-12) as a springboard to help educate the public on the importance of influenza vaccination throughout the winter. Vaccination rates typically decline after Thanksgiving, although the peak of influenza season usually occurs in February and March.

"NACCHO is pleased to partner with MedImmune to help increase the number of individuals vaccinated against influenza," said NACCHO President Gary Cox, J.D. "These doses of vaccine will go a long way to support a national objective of immunizing all persons who should receive flu vaccine, especially those who are least able to afford it."

Public health guidelines on annual influenza vaccination are broader than ever before. In February 2008, the CDC's Advisory Committee on Immunization Practices (ACIP) voted to expand pediatric influenza vaccination recommendations to include school-age children ages 5 through 18 years. The expanded recommendations add 30 million children to the recommended pediatric population for annual influenza vaccination. In addition to influenza vaccination recommendations for specific populations (http://www.cdc.gov/flu), the CDC recommends that anyone w
'/>"/>

SOURCE NACCHO
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AT&T Supports the Smith Familys Learning For Life Program
2. American Lung Association Announces Support of Pickens Plan
3. Video: Childhood Influenza Immunization Coalition Supports Second Annual Childrens Flu Vaccination Day
4. Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health
5. Turn to Diabetic Care Services for Personalized Support and Hassle-Free Diabetes Supplies
6. Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus
7. Over 40 Hospitals Lend Support for Individual Insurance Market Reform
8. Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
9. International study supports new standard of treatment for women with advanced ovarian cancer
10. MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care
11. Canada Supports Ground-Breaking Malaria Treatment Program in Sub-Saharan Africa
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 2Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 3Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 4Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 5Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 6Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 7Health News:Heart Association Renews Call for CPR Training 2Health News:Heart Association Renews Call for CPR Training 3Health News:QLT reduces workforce as first step in its strategic restructure 2Health News:QLT reduces workforce as first step in its strategic restructure 3Health News:Ad Campaign Targets Abuses by Not-For-Profits 2Health News:Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed 2Health News:Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed 3Health News:Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed 4Health News:Immune Therapy May Help Some Heart Failure Patients 2Health News:Immune Therapy May Help Some Heart Failure Patients 3
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2VA Announces 2426 Million Construction Contract for Palo Alto 51841 1Vein Removal Method Linked to Bypass Results 51837 1Vein Removal Method Linked to Bypass Results 51837 2Vein Removal Method Linked to Bypass Results 51837 3Affordable Health Choices Act Is an Excellent Step Toward Health Care Reform 51832 1Affordable Health Choices Act Is an Excellent Step Toward Health Care Reform 51832 2